News|Articles|July 24, 2024
Accelerating Small Molecule Advancements: The Power of Collaboration Between CDMOs and Biotechs (July 2024)
Author(s)Lonza
The increasing number of breakthroughs in small molecule drug development are exciting, but corresponding workflows are complex and require much more tailored approaches to ensure successful upstream and downstream processing, drug approvals and commercialization.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
The Year of AI: 2025’s Bio/pharma Upskilling Revolution
2
How GLP-1s, Digital Tech, and 505(b)(2) Strategies Are Reshaping the CDMO Landscape
3
Onshoring Requires a Plan for Training
4
Strategies for Building Pharmaceutical Supply Chain Resilience in a Shifting Market
5